| Application no. and date | 21714345.2 (espacenet) (Federated) (European Patent Register), 20210316 | | Patent/reg. no. and date | DK/EP 4106757, 20230823 | | Publication date | 20221228 | | Priority no. and date | GB 202005519, 20200416, GB 202005520, 20200416, US 202062706195 P, 20200804 | | EP pub. no. and date |
EP 4106757 20221228 | | Effective date | | | Applicant/owner | Mereo Biopharma 4 Limited, 1 Cavendish Place
London
Greater London W1G 0QF, GB | | Applicant ref. no. | P82852DK01 | | Inventor | PARKIN, Jacqueline, 1 Cavendish Place
London W1G 0QF, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/444 (2006.01) , A61K 45/06 (2006.01) , A61P 11/00 (2006.01) , A61P 29/00 (2006.01) | | Title | FREMGANGSMÅDER DER INVOLVERER NEUTROFIL ELASTASE-INHIBITOR ALVELESTAT TIL BEHANDLING AF LUFTVEJSSYGDOM MEDIERET AF ALPHA-1-ANTITRYPSIN-MANGEL | | Int. application no. | GB2021050653 | | Int. publication no. | WO2021209739 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
